Smith & Nephew SNATS (SNN)
(Real Time Quote from BATS)
$24.45 USD
+0.57 (2.39%)
Updated Apr 26, 2024 03:35 PM ET
4-Sell of 5 4
A Value B Growth B Momentum A VGM
Smith & Nephew (SNN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$33.50 | $34.00 | $33.00 | 40.28% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Smith & Nephew comes to $33.50. The forecasts range from a low of $33.00 to a high of $34.00. The average price target represents an increase of 40.28% from the last closing price of $23.88.
Analyst Price Targets (2 )
Broker Rating
Smith & Nephew currently has an average brokerage recommendation (ABR) of 1.44 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.44 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, seven are Strong Buy, representing 77.78% of all recommendations. A month ago, Strong Buy represented 77.78%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.44 | 1.44 | 1.44 | 1.44 | 1.44 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
Not Identified | Not Identified | Not Identified | Not Identified | Not Identified |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.44 |
ABR (Last week) | 1.44 |
# of Recs in ABR | 9 |
Average Target Price | $33.50 |
LT Growth Rate | 10.50% |
Industry | Medical - Products |
Industry Rank by ABR | 140 of 252 |
Current Quarter EPS Est: | NA |